Caffeine

CHEMBL113 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
194.2 g/mol
LogP
-0.1
Phase
4

A widely consumed methylxanthine stimulant that blocks adenosine receptors in the brain, promoting wakefulness and alertness. Medically, it is used in combination with analgesics for headaches, as a respiratory stimulant in premature infants, and is being studied for neuroprotective effects in conditions like Parkinson's disease. Excessive intake can cause anxiety, insomnia, and elevated heart rate.

分子量

194.1900 g/mol

LogP

-0.10

TPSA

58.40 Ų

リピンスキーの五則

適合

治療領域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cn1c(=O)c2c(ncn2C)n(C)c1=O

InChI

InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3

Molecular Formula

C8H10N4O2

HBD / HBA

- / 3

回転可能結合数

0

重原子数

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A widely consumed methylxanthine stimulant that blocks adenosine receptors in the brain, promoting wakefulness and alertness. Medically, it is used in combination with analgesics for headaches, as a respiratory stimulant in premature infants, and is being studied for neuroprotective effects in conditions like Parkinson's disease. Excessive intake can cause anxiety, insomnia, and elevated heart rate.

Yes, Caffeine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL113. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2519. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.